Cefepime Hydrochloride

CAS 123171-59-5 7 current recordsSmall Molecule

Who holds supplier records for Cefepime Hydrochloride? 7 organisations hold a current record for Cefepime Hydrochloride: an active US FDA Type II Drug Master File or a CEP. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), Italy (2) and China (2).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Cefepime Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cefepime-hydrochloride

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cefepime Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Cefepime Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (5)

Certificates of Suitability on the EDQM register for Cefepime Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 10 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. ShenzhenCN
CEP 2025-472 - Rev 00
Cefepime dihydrochloride monohydrate, Sterile
Nov 2026—
FRESENIUS KABI IPSUM S.R.L. VilladoseIT
CEP 2022-460 - Rev 01
Cefepime dihydrochloride monohydrate, Sterile, process 2
Oct 2026Inspected May 2026
Italy
ACS DOBFAR S.P.A. TribianoIT
CEP 2023-021 - Rev 01
Cefepime dihydrochloride monohydrate, Sterile
Nov 2025—
QILU ANTIBIOTICS PHARMACEUTICAL CO. LTD. JinanCN
CEP 2011-286 - Rev 02
Cefepime dihydrochloride monohydrate, Sterile
May 2025Inspected Jun 2026
Austria
ORCHID PHARMA LIMITED AlathurIN
CEP 2008-081 - Rev 03
Cefepime dihydrochloride monohydrate, Sterile
Sept 2024Inspected Oct 2024
Poland

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Cefepime Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200962).

Chemical identity

IUPAC name
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;chloride;hydrate;hydrochloride
Canonical SMILES
C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
InChIKey
LRAJHPGSGBRUJN-OMIVUECESA-N
Synonyms
BMY-28142 2HCL.H20, BMY-28142 2HCL.H2O, BMY-28142 DIHYDROCHLORIDE MONOHYDRATE, Cefepime (as hydrochloride), Cefepime dihydrochloride hydrate, Cefepime dihydrochloride monohydrate, Cefepime hcl, Cefepime hydrochloride, Cefepime hydrochloride (arginine formulation), Cefepime hydrochloride component of exblifep, Cefepime hydrochloride monohydrate, Exblifep

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Cephalosporin Antibacterial
Chemical structure
Cephalosporins

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cefepime Hydrochloride?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Cefepime Hydrochloride: FRESENIUS KABI IPSUM SRL (Italy), Orchid Pharma Limited (India), Ceph Lifesciences Private Limited (India), Nectar Lifesciences Limited (India), ACS DOBFAR SPA (Italy), Qilu Antibiotics Pharmaceutical Co., Ltd. (China) and Shenzhen Salubris Pharmaceuticals Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cefepime Hydrochloride Drug Master Files are active?

FRESENIUS KABI IPSUM SRL (DMF 27971), Orchid Pharma Limited (DMF 18902), Ceph Lifesciences Private Limited (DMF 25017) and Nectar Lifesciences Limited (DMF 25016). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does Cefepime Hydrochloride have a European Certificate of Suitability?

Yes. 5 organisations hold a valid CEP for Cefepime Hydrochloride on the EDQM register, including SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Shenzhen (CN), FRESENIUS KABI IPSUM S.R.L. Villadose (IT), ACS DOBFAR S.P.A. Tribiano (IT), QILU ANTIBIOTICS PHARMACEUTICAL CO. LTD. Jinan (CN) and ORCHID PHARMA LIMITED Alathur (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Cefepime Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cefepime Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.